SLS
NASDAQ · Biotechnology
Sellas Life Sciences Group I
$8.05
+0.29 (+3.74%)
Earnings Summary
Beats (Last 1)
1/1
Avg Surprise
+23.9%
Consecutive Beats
1 quarter
Latest EPS
$-0.05
History
1 quarter
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| May 11, 2026 | Q2 FY2026 | $-0.04 | — | — | — | — |
| Mar 19, 2026 | Q1 FY2026 | $-0.07 | $-0.05 | +$0.02 | +23.9% | Beat |
| Mar 18, 2026 | Q1 FY2026 | $-0.07 | — | — | — | — |